Using nicotine to improve hearing in older adults
Using nicotine to reverse age-related auditory processing deficits
This study is looking at whether nicotine can help older adults hear better and understand speech more clearly, especially when combined with hearing aids and training, to improve their overall quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11003366 on NIH RePORTER |
What this research studies
This research investigates how nicotine may help reverse age-related hearing deficits that affect speech perception and overall quality of life in older adults. The study aims to develop biomarkers to understand auditory processing changes in aging individuals and test whether nicotine can normalize these deficits. By combining drug treatment with hearing aids and behavioral training, the research seeks to provide a comprehensive approach to improving auditory function. The methodology includes testing on both aging mice and humans to gather insights into the effectiveness of nicotine in enhancing auditory processing.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing age-related hearing loss or auditory processing deficits.
Not a fit: Patients with hearing loss due to non-age-related factors or those who do not have auditory processing deficits may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve hearing and cognitive function in older adults.
How similar studies have performed: Previous research has shown promising results in using pharmacological approaches to address cognitive deficits in aging, suggesting potential for success in this novel application of nicotine.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Metherate, Raju — University of California-Irvine
- Study coordinator: Metherate, Raju
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.